TRANSENTERIX INC's ticker is TRXC and the CUSIP is 89366M201. A total of 156 filers reported holding TRANSENTERIX INC in Q3 2018. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,249,000 | – | 215,385 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 7,546,692 | $10,792,000 | 8.18% |
| StepStone Group LP | 3,032,625 | $4,336,000 | 2.87% |
| Aisling Capital LLC | 10,335,819 | $14,780,000 | 2.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 889,082 | $1,271,000 | 0.50% |
| ELEMENT CAPITAL MANAGEMENT LLC | 249,959 | $357,000 | 0.15% |
| MASTERS CAPITAL MANAGEMENT LLC | 4,000,000 | $5,720,000 | 0.13% |
| BRANDYWINE MANAGERS, LLC | 49,000 | $70,000 | 0.02% |
| NATIONAL PLANNING CORP | 159,250 | $228,000 | 0.02% |
| Jacobi Capital Management LLC | 30,000 | $45,000 | 0.02% |
| AE Wealth Management LLC | 106,010 | $152,000 | 0.01% |